Stratification in clinical research refers to the process of dividing study participants into subgroups based on specific characteristics or factors. These factors can include age, gender, disease severity, or other relevant variables that might influence the study outcomes.
The primary purpose of stratification is to ensure a balanced distribution of important variables across treatment groups. By doing so, researchers can minimize bias, increase statistical power, and improve the validity of their results when comparing different interventions or treatments.
Stratification is crucial in clinical research as it helps control for confounding variables that could skew study results. By ensuring a balanced distribution of key characteristics across treatment groups, researchers can more accurately attribute observed effects to the intervention being studied rather than to pre-existing differences between groups.
Furthermore, stratification enhances the statistical power and efficiency of clinical trials. It allows for more precise subgroup analyses, which can reveal important differences in treatment effects among specific patient populations, ultimately leading to more personalized and effective medical interventions.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant